Literature DB >> 3917129

Formation of DNA-adducts and induction of DNA-crosslinks and chromosomal aberrations by the new potent anthracycline antitumor antibiotics: morpholinodaunomycin, cyanomorpholinodaunomycin and cyanomorpholinoadriamycin.

J Westendorf1, G Groth, G Steinheider, H Marquardt.   

Abstract

The DNA-interaction of three newly developed semisynthetic anthracyclines with high antitumor potency MoDNM3, CNMoDNM, and CNMoADM, was investigated. When primary rat hepatocytes were incubated with tritium labeled MoDNM and CNMoDNM and their DNA was purified and enzymatically hydrolized, the formation of DNA-adducts could be demonstrated by the HPLC chromatography of the resulting mononucleoside mixtures. The parent compound, daunomycin (DNM), also formed covalent adducts with hepatocyte DNA, but to a lesser extent. These findings correlate well with earlier observations that MoDNM and CNMoDNM are potent inducers of DNA-repair in primary rat hepatocytes, whereas DNM is only weakly active in this regard. Alkaline elution studies were performed with L 1210 mouse leukemia cells and V79 Chinese hamster fibroblasts. The cyanomorpholinyl derivatives showed dose-dependent DNA crosslinking activities in both cell lines at concentrations greater than or equal to 5 nMol/l. The formation of crosslinks began a few minutes after treatment of the cells and reached a maximum after 1 hr. In contrast, MoDNM, at concentrations of up to 10 muMol/l, had only a limited capacity to induce single strand breaks in L 1210 cells but did not induce DNA-crosslinks. In addition, chromosomal aberrations (chromatid breaks and translocations) were induced by the treatment of Friend and L 1210 leukemia cells with CNMoADM at concentrations between 0.07-0.6 nMol/l. At higher doses, chromosome clumping was observed. These results indicate that the high capacity of MoDNM, CNMoDNM and CNMoADM to induce DNA repair in primary rat hepatocytes is due to the formation of covalent adducts with DNA. The cyanomorpholino compounds have alkylating capacities also in cell lines such as L 1210 and V79, whereas MoDNM requires rat hepatocytes for activation. The ready formation of DNA crosslinks and chromosomal aberrations could be responsible for the high cytotoxicity of these compounds.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917129     DOI: 10.1007/bf00717794

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  11 in total

1.  Fractionation of DNA from mammalian cells by alkaline elution.

Authors:  K W Kohn; L C Erickson; R A Ewig; C A Friedman
Journal:  Biochemistry       Date:  1976-10-19       Impact factor: 3.162

2.  Chromosome aberrations induced in human leukocytes by the antileukemic antibiotic adriamycin.

Authors:  B K Vig
Journal:  Cancer Res       Date:  1971-01       Impact factor: 12.701

3.  Evidence for covalent binding of adriamycin to rat liver microsomal proteins.

Authors:  P Ghezzi; M G Donelli; C Pantarotto; T Facchinetti; S Garattini
Journal:  Biochem Pharmacol       Date:  1981-01-15       Impact factor: 5.858

4.  Structure-activity relationship of anthracycline-induced genotoxicity in vitro.

Authors:  J Westendorf; H Marquardt; H Marquardt
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

5.  Enzymatic activation and binding of adriamycin to nuclear DNA.

Authors:  B K Sinha; M A Trush; K A Kennedy; E G Mimnaugh
Journal:  Cancer Res       Date:  1984-07       Impact factor: 12.701

6.  Rat hepatocyte primary cell cultures. III. Improved dissociation and attachment techniques and the enhancement of survival by culture medium.

Authors:  G M Williams; E Bermudez; D Scaramuzzino
Journal:  In Vitro       Date:  1977

7.  Intensely potent morpholinyl anthracyclines.

Authors:  E M Acton; G L Tong; C W Mosher; R L Wolgemuth
Journal:  J Med Chem       Date:  1984-05       Impact factor: 7.446

8.  Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin.

Authors:  C W Mosher; H Y Wu; A N Fujiwara; E M Acton
Journal:  J Med Chem       Date:  1982-01       Impact factor: 7.446

9.  Qualitative and quantitative aspects of intercalator-induced DNA strand breaks.

Authors:  W E Ross; D Glaubiger; K W Kohn
Journal:  Biochim Biophys Acta       Date:  1979-03-28

10.  Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.

Authors:  L A Zwelling; S Michaels; L C Erickson; R S Ungerleider; M Nichols; K W Kohn
Journal:  Biochemistry       Date:  1981-11-10       Impact factor: 3.162

View more
  8 in total

1.  Neurotoxicity and dermatotoxicity of cyanomorpholinyl adriamycin.

Authors:  S C Cramer; R H Rhodes; E M Acton; Z A Tökés
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Induction of chromosomal aberrations by the anthracycline antitumor antibiotics N,N-dimethyldaunomycin and aclacinomycin A.

Authors:  G Steinheider; J Westendorf; H Marquardt
Journal:  Experientia       Date:  1987-05-15

3.  The genotoxicity of lucidin, a natural component of Rubia tinctorum L., and lucidinethylether, a component of ethanolic Rubia extracts.

Authors:  J Westendorf; B Poginsky; H Marquardt; G Groth; H Marquardt
Journal:  Cell Biol Toxicol       Date:  1988-06       Impact factor: 6.691

4.  Induction of malignant transformation in vitro and mammary tumors in rats by two new potent anthracycline antitumor antibiotics, morpholinodaunomycin and cyanomorpholinoadriamycin.

Authors:  J Westendorf; U Mohr; H Marquardt
Journal:  Cell Biol Toxicol       Date:  1987-03       Impact factor: 6.691

5.  Covalent modification of DNA by daunorubicin.

Authors:  M Purewal; J G Liehr
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Induction of erythroid differentiation by the anthracycline antitumor antibiotic pyrromycin.

Authors:  G Steinheider; A Schaefer; J Westendorf; H Marquardt
Journal:  Cell Biol Toxicol       Date:  1988-03       Impact factor: 6.691

7.  Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and -resistant P388 cells.

Authors:  D G Streeter; J S Johl; G R Gordon; J H Peters
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

8.  L1210 cells selected for resistance to methoxymorpholinyl doxorubicin appear specifically resistant to this class of morpholinyl derivatives.

Authors:  C Geroni; E Pesenti; M Broggini; G Belvedere; G Tagliabue; M D'Incalci; G Pennella; M Grandi
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.